Respiforce Liquid
FDA Label NDC 43857-0623

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Bioactive Nutritional, Inc. for the product Respiforce (NDC 43857-0623). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding active ingredients:, indications:, warnings:, keep out of reach of children:, directions:, indications and usage:, inactive ingredients:, questions:, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Active Ingredients:

Carbo Vegetabilis 30X, Cuprum Metallicum 30X, Drosera (Rotundifolia) 30X, Ipecacuanha 30X, Lachesis Mutus 30X, Lobelia Inflata 30X, Phosphorus 30X, Pulsatilla (Vulgaris) 30X, Rumex Crispus 30X, Spongia Tosta 30X

Indications:

For temporary relief of symptoms due to cough and upper respiratory infection.

Warnings:

If pregnant or breast-feeding, ask a health care professional before use.

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Do not use if tamper evident seal is broken or missing.

Store in cool, dry place.

Keep Out Of Reach Of Children:

KEEP OUT OF REACH OF CHILDREN. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions:

10 drops orally, 3 times a day. Consult a physician for use in children under 12 years of age.

Indications And Usage:

For temporary relief of symptoms due to cough and upper respiratory infection.

Inactive Ingredients:

Demineralized Water, 25% Ethanol

Questions:

Distributed by:
BioActive Nutritional, Inc.
1803 N. Wickham Rd.
Melbourne, FL 32935
bioactivenutritional.com

Package Label Display:

BIOActiveNutritional

RESPIFORCE B-HP

HOMEOPATHIC

1 FL OZ (30 ml)

* Please review the disclaimer below.